These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 8915680

  • 1. Heterogeneity of drug susceptibility of mouse active anaphylactic shock.
    Kimura S, Watanabe A, Nagata M, Niinomi Y, Harada M.
    Immunol Invest; 1996; 25(5-6):425-34. PubMed ID: 8915680
    [Abstract] [Full Text] [Related]

  • 2. Suppressive effects of antihistaminic and/or anti-PAF agents on passive anaphylactic shock in mice sensitized with allogeneic monoclonal IgE and IgG1 antibodies and hyperimmune serum.
    Kimura S, Watanabe A, Takeuchi M, Nagata M, Harada M.
    Immunol Invest; 1998 Dec; 27(6):379-93. PubMed ID: 9845423
    [Abstract] [Full Text] [Related]

  • 3. Differential effect of a PAF antagonist CV-3988 on active and passive anaphylactic shock in various mouse strains.
    Arimura A, Harada M.
    Lipids; 1991 Dec; 26(12):1386-90. PubMed ID: 1819738
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Production of active and passive anaphylactic shock in the WBB6F1 mouse, a mast cell-deficient strain.
    Arimura A, Nagata M, Watanabe A, Nakamura K, Takeuchi M, Harada M.
    Experientia; 1990 Jul 15; 46(7):739-42. PubMed ID: 2373200
    [Abstract] [Full Text] [Related]

  • 6. Anti-granulocyte antibody suppression of active and passive anaphylactic shock in WBB6F1-W/Wv mice.
    Kimura S, Nagata M, Takeuchi M, Takano K, Harada M.
    Cell Mol Life Sci; 1997 Aug 15; 53(8):663-6. PubMed ID: 9351469
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High susceptibility of cataract Shionogi (CTS) mice to passive anaphylactic shock mediated by allogeneic IgE and IgG1 monoclonal antibodies.
    Harada M, Nagata M, Takeuchi M, Makino S, Aburahi S.
    Immunol Invest; 1991 Jun 15; 20(3):305-15. PubMed ID: 1874560
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Age-dependent difference in susceptibility to IgE antibody- and IgG1 antibody-mediated passive anaphylactic shock in the mouse.
    Harada M, Nagata M, Takeuchi M, Ohara T, Makino S, Watanabe A.
    Immunol Invest; 1991 Jun 15; 20(5-6):515-23. PubMed ID: 1791039
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A lethal role of platelet activating factor in anaphylactic shock in mice.
    Terashita Z, Imura Y, Shino A, Nishikawa K.
    J Pharmacol Exp Ther; 1987 Oct 15; 243(1):378-83. PubMed ID: 3118009
    [Abstract] [Full Text] [Related]

  • 14. [Antigenicity studies of prulifloxacin (NM441)].
    Tateda C, Sakai K, Yamakawa S, Nakasuji T, Nakamura T, Sumi N, Shindo Y.
    J Toxicol Sci; 1996 Jun 15; 21 Suppl 1():231-9. PubMed ID: 8709164
    [Abstract] [Full Text] [Related]

  • 15. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
    Terashita Z, Kawamura M, Takatani M, Tsushima S, Imura Y, Nishikawa K.
    J Pharmacol Exp Ther; 1992 Feb 15; 260(2):748-55. PubMed ID: 1738121
    [Abstract] [Full Text] [Related]

  • 16. Active and passive cutaneous anaphylaxis in WBB6F1 mouse, a mast cell-deficient strain.
    Arimura A, Nagata M, Takeuchi M, Watanabe A, Nakamura K, Harada M.
    Immunol Invest; 1990 Jun 15; 19(3):227-33. PubMed ID: 2365426
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Modification of the clinical and histopathologic expression of experimental allergic encephalomyelitis by the vasoactive amine antagonist cyproheptadine.
    Waxman FJ, Taguiam JM, Whitacre CC.
    Cell Immunol; 1984 Apr 15; 85(1):82-93. PubMed ID: 6201289
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.